Exploiting DNA repair defects in triple negative breast cancer to improve cell killing

BACKGROUND: The lack of molecular targets for triple negative breast cancer (TNBC) has limited treatment options and reduced survivorship. Identifying new molecular targets may help improve patient survival and decrease recurrence and metastasis. As DNA repair defects are prevalent in breast cancer,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Kevin J., Mann, Elise, Wright, Griffin, Piett, Cortt G., Nagel, Zachary D., Gassman, Natalie R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502856/
https://www.ncbi.nlm.nih.gov/pubmed/32994807
http://dx.doi.org/10.1177/1758835920958354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502856/
https://www.ncbi.nlm.nih.gov/pubmed/32994807
http://dx.doi.org/10.1177/1758835920958354

Ejemplares similares